Kranthi Kumar Chintala
About Kranthi Kumar Chintala
Data last updated:
Kranthi Kumar Chintala is an Additional Director at Katzung Pharmaceuticals Private Limited (since 2017), Designated Partner at Pulse Heart Super Speciality Hospital Llp (since 2023) and Director at Power Consent Solutions Private Limited (since 2020). The companies operate in Pharma, Healthcare and Business Outsourcing. The largest current company by reported revenue is Katzung Pharmaceuticals Private Limited at ₹6.17 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Katzung Pharmaceuticals Private Limited U74999TG2017PTC117959 | Additional Director | 08 Jul 2017 | 2017 | ₹6.17 Cr (FY 2024) | Active |
| Designated Partner | 11 Jan 2023 | 2023 | Active | ||
 Power Consent Solutions Private Limited U74999TG2020PTC146108 | Director | 20 Nov 2020 | 2020 | Active |
Board colleagues of Kranthi Kumar Chintala
| Name | DIN | Company | Designation |
|---|---|---|---|
| Amar Vennapusa | 07595055 | Katzung Pharmaceuticals Private Limited | Director |
| Mahesh Babu Jambuladinne | 07857647 | Katzung Pharmaceuticals Private Limited | Director |
| Syam Sundar Mukharjee Madivada | 07183706 | Katzung Pharmaceuticals Private Limited , Pulse Heart Super Speciality Hospital Llp and 1 more | Director |
| Narasimha Raj Mandapati | 08967559 | Power Consent Solutions Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Kranthi Kumar Chintala
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kranthi Kumar Chintala
Kranthi Kumar Chintala currently holds 3 directorships: Katzung Pharmaceuticals Private Limited (Additional Director, since 08 Jul 2017, revenue ₹6.17 Cr (FY 2024)); Pulse Heart Super Speciality Hospital Llp (Designated Partner, since 11 Jan 2023); Power Consent Solutions Private Limited (Director, since 20 Nov 2020).
Kranthi Kumar Chintala was first appointed on 08 Jul 2017 as Additional Director at Katzung Pharmaceuticals Private Limited. The most recent appointment on record is 11 Jan 2023 at Pulse Heart Super Speciality Hospital Llp.
The current boards of Kranthi Kumar Chintala's companies include Amar Vennapusa (Katzung Pharmaceuticals Private Limited), Mahesh Babu Jambuladinne (Katzung Pharmaceuticals Private Limited), Syam Sundar Mukharjee Madivada (Katzung Pharmaceuticals Private Limited), Narasimha Raj Mandapati (Power Consent Solutions Private Limited).